Primecap Management CO Sanofi Transaction History

Primecap Management CO

$126 Billion
Q3 2025

A detailed history of Primecap Management CO transactions in Sanofi stock. As of the latest transaction made, Primecap Management CO holds 986,468 shares of SNY stock, worth $51.1 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

986,468

Previous 1,135,528 13.13%

Holding current value

$51.1 Million

Previous $54.9 Million 15.12%

% of portfolio

0.04%

Previous 0.04%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 10, 2025	SELL	$45.07 - $51.35 $6.72 Million - $7.65 Million	-149,060 Reduced 13.13%	986,468 $46.6 Million
Q2 2025 Aug 11, 2025	BUY	$47.62 - $55.44 $1.66 Million - $1.93 Million	34,890 Added 3.17%	1,135,528 $54.9 Million
Q1 2025 May 09, 2025	SELL	$48.15 - $59.42 $495,463 - $611,431	-10,290 Reduced 0.93%	1,100,638 $61 Million
Q4 2024 Feb 10, 2025	SELL	$45.89 - $57.31 $232,662 - $290,561	-5,070 Reduced 0.45%	1,110,928 $53.6 Million
Q3 2024 Nov 08, 2024	SELL	$48.54 - $58.53 $64,558 - $77,844	-1,330 Reduced 0.12%	1,115,998 $64.3 Million

Q2 2024 Aug 09, 2024	SELL	$45.39 - $50.36 $96,317 - $106,863	-2,122 Reduced 0.19%	1,117,328 $54.2 Million
Q1 2024 May 13, 2024	SELL	$45.75 - $52.48 $163,785 - $187,878	-3,580 Reduced 0.32%	1,119,450 $54.4 Million
Q4 2023 Feb 09, 2024	SELL	$43.13 - $54.79 $170,794 - $216,968	-3,960 Reduced 0.35%	1,123,030 $55.8 Million
Q3 2023 Nov 13, 2023	SELL	$50.95 - $55.2 $259,845 - $281,520	-5,100 Reduced 0.45%	1,126,990 $60.5 Million
Q2 2023 Aug 11, 2023	SELL	$50.45 - $57.18 $2.87 Million - $3.26 Million	-56,960 Reduced 4.79%	1,132,090 $61 Million
Q1 2023 May 15, 2023	SELL	$45.86 - $54.45 $1.22 Million - $1.45 Million	-26,690 Reduced 2.2%	1,189,050 $64.7 Million
Q4 2022 Feb 13, 2023	SELL	$38.86 - $48.55 $923,313 - $1.15 Million	-23,760 Reduced 1.92%	1,215,740 $58.9 Million
Q2 2022 Aug 11, 2022	SELL	$48.99 - $57.46 $291,000 - $341,312	-5,940 Reduced 0.48%	1,239,500 $62 Million
Q1 2022 May 11, 2022	SELL	$48.48 - $53.65 $214,281 - $237,133	-4,420 Reduced 0.35%	1,245,440 $63.9 Million
Q4 2021 Feb 11, 2022	SELL	$47.07 - $52.35 $4.64 Million - $5.16 Million	-98,500 Reduced 7.31%	1,249,860 $62.6 Million
Q3 2021 Nov 12, 2021	SELL	$47.89 - $53.12 $1.52 Million - $1.69 Million	-31,750 Reduced 2.3%	1,348,360 $65 Million
Q2 2021 Aug 10, 2021	SELL	$49.36 - $54.25 $616,012 - $677,040	-12,480 Reduced 0.9%	1,380,110 $72.7 Million
Q1 2021 May 14, 2021	SELL	$45.46 - $50.51 $14.1 Million - $15.7 Million	-310,970 Reduced 18.25%	1,392,590 $68.9 Million
Q4 2020 Feb 08, 2021	SELL	$45.3 - $51.62 $1.75 Million - $1.99 Million	-38,610 Reduced 2.22%	1,703,560 $82.8 Million
Q3 2020 Nov 13, 2020	SELL	$49.47 - $53.77 $3.73 Million - $4.06 Million	-75,470 Reduced 4.15%	1,742,170 $87.4 Million
Q2 2020 Aug 13, 2020	SELL	$42.91 - $52.5 $1.84 Million - $2.25 Million	-42,900 Reduced 2.31%	1,817,640 $92.8 Million
Q1 2020 May 14, 2020	SELL	$38.02 - $51.66 $1.89 Million - $2.57 Million	-49,760 Reduced 2.6%	1,860,540 $81.3 Million
Q4 2019 Feb 14, 2020	BUY	$44.25 - $50.86 $265,500 - $305,160	6,000 Added 0.32%	1,910,300 $95.9 Million
Q3 2019 Nov 13, 2019	SELL	$40.34 - $46.64 $661,576 - $764,896	-16,400 Reduced 0.85%	1,904,300 $88.2 Million
Q2 2019 Aug 14, 2019	SELL	$40.43 - $44.3 $1.42 Million - $1.55 Million	-35,000 Reduced 1.79%	1,920,700 $83.1 Million
Q3 2018 Nov 13, 2018	SELL	$40.0 - $44.84 $12,000 - $13,452	-300 Reduced 0.02%	1,955,700 $87.4 Million
Q4 2017 Feb 13, 2018	SELL	$42.86 - $50.61 $429,200 - $506,808	-10,014 Reduced 0.51%	1,956,000 $84.1 Million
Q3 2017 Nov 13, 2017	BUY	$47.04 - $50.34 $92.5 Million - $99 Million	1,966,014	1,966,014 $97.9 Million

Others Institutions Holding SNY

# of Institutions

829

Shares Held

250M

Call Options Held

2.45M

Put Options Held

2.51M

View Full List

About Sanofi

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $130B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

More about SNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Primecap Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Primecap Management CO with notifications on news.

Account

Primecap Management CO Sanofi Transaction History